Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Alkermes Plc. (ALKS)
since 2015 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Alkermes Plc..
Table 2 shows the detailed insider transactions.
This company's CIK number is 1520262.
Total stock buying since 2015: $1,582,948.
Total stock sales since 2015: $221,939,344.
Total stock option exercises since 2015: $86,692,070.
Table 3. Detailed insider trading at Alkermes Plc. (ALKS)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2025-08-03 | Gaffin David Joseph (EVP, CLO, Alkermes, Inc.) | Option Ex | 2,014 | .00 | 0 |
| 2025-06-10 | Nichols Christian Todd (SVP, Chief Commercial Officer) | Sale | 3,334 | 31.09 | 103,654 |
| 2025-06-09 | Nichols Christian Todd (SVP, Chief Commercial Officer) | Sale | 3,333 | 31.95 | 106,489 |
| 2025-06-08 | Wright Christopher I (Director) | Option Ex | 3,301 | .00 | 0 |
| 2025-05-31 | Wright Christopher I (Director) | Option Ex | 8,013 | .00 | 0 |
| 2025-05-31 | Snyderman Nancy Lynn Md (Director) | Option Ex | 8,013 | .00 | 0 |
| 2025-05-31 | Wilson Frank Anders (Director) | Option Ex | 8,013 | .00 | 0 |
| 2025-05-31 | Lurker Nancy (Director) | Option Ex | 8,013 | .00 | 0 |
| 2025-05-31 | Mckeon Brian P (Director) | Option Ex | 8,013 | .00 | 0 |
| 2025-04-11 | Lurker Nancy (Director) | Option Ex | 6,075 | .00 | 0 |
| 2025-02-28 | Parisi Samuel Joseph (VP, Finance (Interim PAO)) | Sale | 1,938 | 34.00 | 65,892 |
| 2025-02-26 | Parisi Samuel Joseph (VP, Finance (Interim PAO)) | Option Ex | 2,746 | .00 | 0 |
| 2025-02-26 | Jackson Blair Curtis (EVP, Chief Operating Officer) | Option Ex | 8,322 | .00 | 0 |
| 2025-02-26 | Nichols Christian Todd (SVP, Chief Commercial Officer) | Option Ex | 5,409 | .00 | 0 |
| 2025-02-26 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Option Ex | 6,866 | .00 | 0 |
| 2025-02-26 | Gaffin David Joseph (EVP, CLO, Alkermes, Inc.) | Option Ex | 6,866 | .00 | 0 |
| 2025-02-26 | Brown Iain Michael (SVP, Chief Financial Officer) | Option Ex | 5,617 | .00 | 0 |
| 2025-02-25 | Parisi Samuel Joseph (VP, Finance (Interim PAO)) | Sale | 3,743 | 35.26 | 131,978 |
| 2025-02-23 | Parisi Samuel Joseph (VP, Finance (Interim PAO)) | Option Ex | 2,284 | .00 | 0 |
| 2025-02-23 | Jackson Blair Curtis (EVP, Chief Operating Officer) | Option Ex | 8,738 | .00 | 0 |
| 2025-02-23 | Nichols Christian Todd (SVP, Chief Commercial Officer) | Option Ex | 6,408 | .00 | 0 |
| 2025-02-23 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Option Ex | 7,689 | .00 | 0 |
| 2025-02-23 | Gaffin David Joseph (EVP, CLO, Alkermes, Inc.) | Option Ex | 7,689 | .00 | 0 |
| 2025-02-23 | Brown Iain Michael (SVP, Chief Financial Officer) | Option Ex | 5,825 | .00 | 0 |
| 2025-02-22 | Parisi Samuel Joseph (VP, Finance (Interim PAO)) | Option Ex | 3,114 | .00 | 0 |
| 2025-02-22 | Jackson Blair Curtis (EVP, Chief Operating Officer) | Option Ex | 9,694 | .00 | 0 |
| 2025-02-22 | Nichols Christian Todd (SVP, Chief Commercial Officer) | Option Ex | 7,109 | .00 | 0 |
| 2025-02-22 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Option Ex | 12,279 | .00 | 0 |
| 2025-02-22 | Gaffin David Joseph (EVP, CLO, Alkermes, Inc.) | Option Ex | 7,432 | .00 | 0 |
| 2025-02-22 | Brown Iain Michael (SVP, Chief Financial Officer) | Option Ex | 7,109 | .00 | 0 |
| 2025-02-20 | Parisi Samuel Joseph (VP, Finance (Interim PAO)) | Sale | 1,327 | 35.69 | 47,360 |
| 2025-02-18 | Parisi Samuel Joseph (VP, Finance (Interim PAO)) | Option Ex | 2,033 | .00 | 0 |
| 2025-02-18 | Jackson Blair Curtis (EVP, Chief Operating Officer) | Option Ex | 8,896 | .00 | 0 |
| 2025-02-18 | Nichols Christian Todd (SVP, Chief Commercial Officer) | Option Ex | 6,354 | .00 | 0 |
| 2025-02-18 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Option Ex | 8,896 | .00 | 0 |
| 2025-02-18 | Gaffin David Joseph (EVP, CLO, Alkermes, Inc.) | Option Ex | 6,354 | .00 | 0 |
| 2025-02-18 | Brown Iain Michael (SVP, Chief Financial Officer) | Option Ex | 6,354 | .00 | 0 |
| 2025-02-13 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Sale | 144,419 | 35.02 | 5,057,553 |
| 2025-02-13 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Option Ex | 144,419 | 28.26 | 4,081,280 |
| 2025-02-12 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Sale | 204,921 | 32.98 | 6,758,294 |
| 2025-02-12 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Option Ex | 199,196 | 19.68 | 3,921,173 |
| 2025-01-30 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Sale | 100,918 | 32.05 | 3,234,421 |
| 2025-01-30 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Option Ex | 97,632 | 22.70 | 2,215,758 |
| 2024-12-09 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Sale | 61,151 | 32.08 | 1,961,418 |
| 2024-12-09 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Option Ex | 48,997 | 22.70 | 1,111,986 |
| 2024-12-09 | Laurencin Cato T (Director) | Sale | 2,691 | 31.85 | 85,708 |
| 2024-12-09 | Laurencin Cato T (Director) | Option Ex | 2,691 | 22.52 | 60,601 |
| 2024-12-08 | Laurencin Cato T (Director) | Option Ex | 4,163 | .00 | 0 |
| 2024-12-05 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Sale | 9,221 | 31.50 | 290,461 |
| 2024-12-04 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Sale | 14,349 | 30.77 | 441,547 |
| 2024-11-27 | Nichols Christian Todd (SVP, Chief Commercial Officer) | Sale | 5,208 | 29.15 | 151,813 |
| 2024-11-11 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Sale | 58,996 | 30.08 | 1,774,599 |
| 2024-11-11 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Option Ex | 43,058 | 20.03 | 862,451 |
| 2024-11-06 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Sale | 10,471 | 29.53 | 309,166 |
| 2024-08-03 | Gaffin David Joseph (EVP, CLO, Alkermes, Inc.) | Option Ex | 2,014 | .00 | 0 |
| 2024-06-29 | Wright Christopher I (Director) | Option Ex | 6,104 | .00 | 0 |
| 2024-06-29 | Daglio David Angelo Jr. (Director) | Option Ex | 6,104 | .00 | 0 |
| 2024-06-29 | Gaynor Richard (Director) | Option Ex | 6,104 | .00 | 0 |
| 2024-06-29 | Alva Emily Peterson (Director) | Option Ex | 6,104 | .00 | 0 |
| 2024-06-29 | Snyderman Nancy Lynn Md (Director) | Option Ex | 6,104 | .00 | 0 |
| 2024-06-29 | Cooke Shane (Director) | Option Ex | 6,104 | .00 | 0 |
| 2024-06-29 | Wilson Frank Anders (Director) | Option Ex | 6,104 | .00 | 0 |
| 2024-06-29 | Laurencin Cato T (Director) | Option Ex | 6,104 | .00 | 0 |
| 2024-06-29 | Mckeon Brian P (Director) | Option Ex | 6,104 | .00 | 0 |
| 2024-06-09 | Alva Emily Peterson (Director) | Option Ex | 3,871 | .00 | 0 |
| 2024-06-08 | Wright Christopher I (Director) | Option Ex | 3,301 | .00 | 0 |
| 2024-03-18 | Nichols Christian Todd (SVP, Chief Commercial Officer) | Sale | 10,417 | 28.10 | 292,738 |
| 2024-02-27 | Parisi Samuel Joseph (VP, Finance (Interim PAO)) | Sale | 2,559 | 29.65 | 75,874 |
| 2024-02-23 | Parisi Samuel Joseph (VP, Finance (Interim PAO)) | Option Ex | 2,283 | .00 | 0 |
| 2024-02-23 | Jackson Blair Curtis (EVP, Chief Operating Officer) | Option Ex | 8,737 | .00 | 0 |
| 2024-02-23 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Option Ex | 7,689 | .00 | 0 |
| 2024-02-23 | Gaffin David Joseph (EVP, CLO, Alkermes, Inc.) | Option Ex | 7,689 | .00 | 0 |
| 2024-02-23 | Brown Iain Michael (SVP, Chief Financial Officer) | Option Ex | 5,825 | .00 | 0 |
| 2024-02-23 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Option Ex | 4,077 | .00 | 0 |
| 2024-02-22 | Parisi Samuel Joseph (VP, Finance (Interim PAO)) | Option Ex | 3,114 | .00 | 0 |
| 2024-02-22 | Jackson Blair Curtis (EVP, Chief Operating Officer) | Option Ex | 9,693 | .00 | 0 |
| 2024-02-22 | Nichols Christian Todd (SVP, Chief Commercial Officer) | Option Ex | 7,108 | .00 | 0 |
| 2024-02-22 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Option Ex | 12,278 | .00 | 0 |
| 2024-02-22 | Gaffin David Joseph (EVP, CLO, Alkermes, Inc.) | Option Ex | 7,431 | .00 | 0 |
| 2024-02-22 | Brown Iain Michael (SVP, Chief Financial Officer) | Option Ex | 7,108 | .00 | 0 |
| 2024-02-22 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Option Ex | 5,654 | .00 | 0 |
| 2024-02-20 | Parisi Samuel Joseph (VP, Finance (Interim PAO)) | Option Ex | 1,872 | .00 | 0 |
| 2024-02-20 | Nichols Christian Todd (SVP, Chief Commercial Officer) | Option Ex | 3,901 | .00 | 0 |
| 2024-02-20 | Gaffin David Joseph (EVP, CLO, Alkermes, Inc.) | Option Ex | 7,177 | .00 | 0 |
| 2024-02-20 | Brown Iain Michael (SVP, Chief Financial Officer) | Option Ex | 4,680 | .00 | 0 |
| 2024-02-20 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Option Ex | 5,461 | .00 | 0 |
| 2024-02-18 | Parisi Samuel Joseph (VP, Finance (Interim PAO)) | Option Ex | 2,034 | .00 | 0 |
| 2024-02-18 | Nichols Christian Todd (SVP, Chief Commercial Officer) | Option Ex | 6,355 | .00 | 0 |
| 2024-02-18 | Gaffin David Joseph (EVP, CLO, Alkermes, Inc.) | Option Ex | 6,355 | .00 | 0 |
| 2024-02-18 | Brown Iain Michael (SVP, Chief Financial Officer) | Option Ex | 6,355 | .00 | 0 |
| 2024-02-18 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Option Ex | 4,448 | .00 | 0 |
| 2024-02-15 | Laurencin Cato T (Director) | Sale | 2,690 | 31.85 | 85,676 |
| 2024-02-15 | Laurencin Cato T (Director) | Option Ex | 2,690 | 22.52 | 60,578 |
| 2024-02-10 | Daglio David Angelo Jr. (Director) | Option Ex | 4,533 | .00 | 0 |
| 2024-02-10 | Mckeon Brian P (Director) | Option Ex | 4,533 | .00 | 0 |
| 2023-12-08 | Laurencin Cato T (Director) | Option Ex | 4,163 | .00 | 0 |
| 2023-08-03 | Gaffin David Joseph (EVP, CLO, Alkermes, Inc.) | Option Ex | 1,974 | .00 | 0 |
| 2023-07-07 | Wright Christopher I (Director) | Option Ex | 5,957 | .00 | 0 |
| 2023-07-07 | Daglio David Angelo Jr. (Director) | Option Ex | 5,957 | .00 | 0 |
| 2023-07-07 | Gaynor Richard (Director) | Option Ex | 5,957 | .00 | 0 |
| 2023-07-07 | Alva Emily Peterson (Director) | Option Ex | 5,957 | .00 | 0 |
| 2023-07-07 | Snyderman Nancy Lynn Md (Director) | Option Ex | 5,957 | .00 | 0 |
| 2023-07-07 | Cooke Shane (Director) | Option Ex | 5,957 | .00 | 0 |
| 2023-07-07 | Wilson Frank Anders (Director) | Option Ex | 5,957 | .00 | 0 |
| 2023-07-07 | Laurencin Cato T (Director) | Option Ex | 5,957 | .00 | 0 |
| 2023-07-07 | Wysenski Nancy (Director) | Option Ex | 5,957 | .00 | 0 |
| 2023-07-07 | Mckeon Brian P (Director) | Option Ex | 5,957 | .00 | 0 |
| 2023-06-09 | Alva Emily Peterson (Director) | Option Ex | 3,795 | .00 | 0 |
| 2023-06-08 | Wright Christopher I (Director) | Option Ex | 3,609 | .00 | 0 |
| 2023-06-08 | Laurencin Cato T (Director) | Sale | 2,638 | 31.85 | 84,020 |
| 2023-06-08 | Laurencin Cato T (Director) | Option Ex | 2,638 | 22.97 | 60,594 |
| 2023-06-07 | Laurencin Cato T (Director) | Sale | 2,800 | 31.50 | 88,200 |
| 2023-06-07 | Laurencin Cato T (Director) | Option Ex | 2,800 | 22.97 | 64,316 |
| 2023-06-05 | Nichols Christian Todd (SVP, Chief Commercial Officer) | Option Ex | 3,500 | .00 | 0 |
| 2023-05-30 | Nichols Christian Todd (SVP, Chief Commercial Officer) | Sale | 27,134 | 28.93 | 784,850 |
| 2023-05-30 | Nichols Christian Todd (SVP, Chief Commercial Officer) | Option Ex | 19,634 | 20.43 | 401,122 |
| 2023-05-09 | Wysenski Nancy (Director) | Sale | 41,250 | 31.24 | 1,288,773 |
| 2023-05-09 | Wysenski Nancy (Director) | Option Ex | 41,250 | 31.13 | 1,284,112 |
| 2023-02-22 | Jackson Blair Curtis (EVP, Chief Operating Officer) | Option Ex | 9,504 | .00 | 0 |
| 2023-02-22 | Nichols Christian Todd (SVP, Chief Commercial Officer) | Option Ex | 6,969 | .00 | 0 |
| 2023-02-22 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Option Ex | 12,038 | .00 | 0 |
| 2023-02-22 | Gaffin David Joseph (EVP, CLO, Alkermes, Inc.) | Option Ex | 7,286 | .00 | 0 |
| 2023-02-22 | Brown Iain Michael (SVP, Chief Financial Officer) | Option Ex | 6,969 | .00 | 0 |
| 2023-02-22 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Option Ex | 5,544 | .00 | 0 |
| 2023-02-21 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Option Ex | 6,875 | .00 | 0 |
| 2023-02-21 | Gaffin David Joseph (EVP, CLO, Alkermes, Inc.) | Option Ex | 6,875 | .00 | 0 |
| 2023-02-21 | Brown Iain Michael (SVP, Chief Financial Officer) | Option Ex | 4,800 | .00 | 0 |
| 2023-02-21 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Option Ex | 5,825 | .00 | 0 |
| 2023-02-20 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Option Ex | 10,095 | .00 | 0 |
| 2023-02-20 | Gaffin David Joseph (EVP, CLO, Alkermes, Inc.) | Option Ex | 7,036 | .00 | 0 |
| 2023-02-20 | Brown Iain Michael (SVP, Chief Financial Officer) | Option Ex | 4,589 | .00 | 0 |
| 2023-02-20 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Option Ex | 5,354 | .00 | 0 |
| 2023-02-18 | Hopkinson Craig C. (EVP R&D, Chief Medical Officer) | Option Ex | 8,722 | .00 | 0 |
| 2023-02-18 | Gaffin David Joseph (EVP, CLO, Alkermes, Inc.) | Option Ex | 6,230 | .00 | 0 |
| 2023-02-18 | Brown Iain Michael (SVP, Chief Financial Officer) | Option Ex | 6,230 | .00 | 0 |
| 2023-02-18 | Landine Michael J (SVP, Corp Dev., Alkermes, Inc.) | Option Ex | 4,361 | .00 | 0 |
| 2023-02-10 | Daglio David Angelo Jr. (Director) | Option Ex | 4,445 | .00 | 0 |
| 2023-02-10 | Mckeon Brian P (Director) | Option Ex | 4,445 | .00 | 0 |
| 2022-12-08 | Laurencin Cato T (Director) | Option Ex | 8,242 | .00 | 0 |
| 2022-11-14 | Daglio David Angelo Jr. (Director) | Buy | 35,000 | 23.31 | 815,745 |
| 2022-06-21 | Nichols Christian Todd (SVP, Chief Commercial Officer) | Sale | 7,474 | 28.26 | 211,200 |
| 2022-06-14 | Daglio David Angelo Jr. (Director) | Option Ex | 7,585 | .00 | 0 |
| 2022-06-14 | Gaynor Richard (Director) | Option Ex | 7,585 | .00 | 0 |
| 2022-06-14 | Alva Emily Peterson (Director) | Option Ex | 7,585 | .00 | 0 |
| 2022-06-14 | Snyderman Nancy Lynn Md (Director) | Option Ex | 7,585 | .00 | 0 |
| 2022-06-14 | Cooke Shane (Director) | Option Ex | 7,585 | .00 | 0 |
| 2022-06-14 | Wilson Frank Anders (Director) | Option Ex | 7,585 | .00 | 0 |
| 2022-06-14 | Wysenski Nancy (Director) | Option Ex | 7,585 | .00 | 0 |
| 2022-06-14 | Mckeon Brian P (Director) | Option Ex | 7,585 | .00 | 0 |
| 2022-06-14 | Dixon Wendy L (Director) | Option Ex | 7,585 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
of ALKS listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Alkermes Plc. (symbol ALKS,
CIK number 1520262) see
the Securities and Exchange Commission (SEC) website.